Everyone is calling them GLP-1, GLP-2 and GLP-3 — but semaglutide, tirzepatide and retatrutide aren’t three generations of the same drug. Here’s what each one actually targets, why the nicknames caught on, and where investigational retatrutide really stands on the road toward FDA approval.
NAD+ and MOTS-c both get called “energy” compounds, but they’re involved in cellular energy in very different ways. Here’s what the science actually says about mitochondria, metabolism, exercise — and why neither one is simply a biological energy drink.
Peptides just stepped into a much bigger conversation. After a major FDA advisory committee meeting involving BPC-157, TB-500, KPV and several other compounds, headlines and social media posts started flying. Here’s what actually happened, what didn’t—and why the distinction matters.
Older dogs running, jumping and playing again after peptides? The stories are getting attention. We looked at BPC-157, TB-500, KPV and ARA-290 to see where intriguing science ends—and anecdote begins.
What happens when losing more weight is no longer the goal? Sometimes the plateau isn’t something to break—it’s the moment to stop chasing smaller and start building stronger.
Shoulder-surgery recovery can take months, but some people using BPC-157 and TB-500 describe surprisingly fast progress. We looked at a real recovery story—and what the human research actually says about these increasingly popular peptides.
NAD+ has become one of the biggest names in longevity and wellness—but what does it actually do? We break down the science behind NAD+, NMN and NR, why they’re being studied for aging and energy, and where the hype gets ahead of the human evidence.
Fatigue, weight gain, low motivation and slower recovery are easy to blame on getting older. Shane’s journey from peptides to TRT raised a different question: when should men stop assuming it’s just age and start looking more closely at their health?
The Compound Edit and Chuk BioWorks share a connection, but serve two different purposes. Here’s how research, education, real-world experiences, and Chuk BioWorks come together—and why transparency matters.
BPC-157 and TB-500 have become some of the most talked-about compounds in injury recovery. From shoulder surgery to stubborn injuries, the stories can sound remarkable—but what does the research actually show, and how much can we learn from real-world experiences?
Retatrutide felt incredibly powerful at first—but now you’re hungry again. Does that mean it stopped working? Here’s why appetite suppression can change over time, and why hunger doesn’t necessarily mean you’ve hit a wall.
